Gore Acquires Pipeline Medical Technologies, Inc.

September 6, 2018—Gore & Associates announced the acquisition of Pipeline Medical Technologies, Inc., which is a privately held medical technology company focused on advancing chordal repair for degenerative mitral regurgitation via a transcatheter procedure.

The company will retain the Pipeline name and operate independently of Gore as a wholly owned subsidiary. Pipeline’s device is currently in development and not available for commercial use.

Paul Sorajja, MD, commented in Gore's announcement, “An entirely catheter-based, transfemoral and transseptal chordal repair will be an important tool for minimally invasive treatment of mitral regurgitation.” Dr. Sorajja is Director, Center for Valve and Structural Heart Disease, Minneapolis Heart Institute at Abbott Northwestern Hospital in Minneapolis, Minnesota.